Blockade of SDF-1/CXCR4 in ovarian cancer using an oncolytic vaccinia virus vector expressing a CXCR4 antagonist inhibited tumor growth by reduction of immunosuppression and targeting of tumor-initiating cells [31]. Here, CXCR4 is linked to neoplasm.